The Chemours Company Announces $455M PFAS Settlement in North Carolina

What Happened

• On September 9, 2026, The Chemours Company, DuPont de Nemours, Inc., Corteva, Inc. and EIDP, Inc. entered into a Settlement Agreement with the State of North Carolina and 11 local entities resolving claims related to PFAS and other emissions from Chemours’ Fayetteville Works facility (and certain state PFAS claims unrelated to the facility, including AFFF use). The agreement calls for an aggregate payment of $455 million, payable over a 15‑year period beginning within 30 days of execution. The Settlement remains subject to entry of orders dismissing the covered claims.
• The filing also notes certain obligations under a 2019 Consent Order have been completed and sets procedures for remaining off‑site obligations (including drinking water programs). Chemours issued a press release on September 10, 2026, describing the settlement and included standard forward‑looking‑statement disclosures.

Key Details

• Settlement Amount: $455,000,000 total, payable over 15 years (payments to begin within 30 days of the September 9, 2026 execution).
• Cost sharing: Per the January 2021 Memorandum of Understanding (MOU), Chemours will be responsible for 50% of settlement payments; DuPont and Corteva will cover the remaining 50%.
• MOU accounting/treatment: For calculating qualified spend against the MOU’s $4.0 billion cap, the Settlement Amount will be applied as $210 million (net present value), spread equally over 25 years using an 8% discount rate; the parties agreed to use this NPV methodology for multi‑year settlements going forward.
• Escrow impact: The North Carolina and the companies’ 2025 New Jersey settlement payments qualify for withdrawal from the MOU escrow and together exceed future escrow contribution obligations; as a result, future escrow contributions (including Chemours’ $50 million contribution due Sept 2026) are considered satisfied.

Why It Matters

• For investors, the agreement reduces a major source of litigation and regulatory uncertainty tied to Fayetteville Works by settling those claims and defining responsibility among the three companies. It commits $455M of aggregate cash obligations paid over time, with Chemours contractually aligned to pay half.
• The MOU NPV treatment and satisfaction of upcoming escrow contributions affect how these payments count against previously agreed caps and escrow requirements, which may influence future cash‑flow timing and accounting for qualified spend under the MOU.
• The settlement is subject to court orders dismissing the covered claims and the press release highlights forward‑looking disclosures and risks (including litigation, remediation costs, and regulatory change) that could still affect outcomes.